Profil
Guru Reddy is the founder of Pangene Corp.
Currently, Dr. Reddy is Vice President-Preclinical Research & Development at Unicycive Therapeutics, Inc. since 2022.
Formerly, Dr. Reddy was Vice President-Preclinical Research & Development at Spectrum Pharmaceuticals, Inc. Education includes a doctorate from Savitribai Phule Pune University.
Postes actifs de Guru Reddy
| Sociétés | Poste | Début |
|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Anciens postes connus de Guru Reddy
| Sociétés | Poste | Fin |
|---|---|---|
Pangene Corp.
Pangene Corp. Pharmaceuticals: MajorHealth Technology Develops oncology drugs based on its DNA repair and recombination platform | Fondateur | - |
| SPECTRUM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Guru Reddy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Pangene Corp.
Pangene Corp. Pharmaceuticals: MajorHealth Technology Develops oncology drugs based on its DNA repair and recombination platform | Health Technology |
Savitribai Phule Pune University
Savitribai Phule Pune University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
















